Healthcare Tracked since Q4 FY26 - Q4 FY26

RPG Life Sciences Limited

RPGLIFESCIENCES

Latest quarter Q4 FY26

Revenue ₹177 Cr (+23.6% YoY)

Management credibility Building

Needs more scored promises across 1 quarters

Latest signal bullish

RPG Life Sciences delivered a strong Q4 FY26 with revenue of 176.9 cr (+23.6% YoY) and EBITDA of 45.2 cr (+48% YoY),...

Quarterly Earnings Timeline

Filing-verified financials, call summary, sentiment, and management-delivery signals by quarter.

1 quarter

Q4 FY26 13 May 2026

bullish high

Revenue ₹177 Cr (+23.6% YoY)

RPG Life Sciences delivered a strong Q4 FY26 with revenue of 176.9 cr (+23.6% YoY) and EBITDA of 45.2 cr (+48% YoY), driven by domestic formulation growth of 18.2% (1....

Scorecard starts after historical backfill Read full analysis →